ATC code M04
| ATC code M:Musculo-skeletal system |
|---|
|
| Other ATC codes |
ATC code M04Antigout preparationsis a therapeutic subgroup of theAnatomical Therapeutic Chemical Classification System,a system of Alpha numeric codes developed by theWorld Health Organization(WHO) for the classification ofdrugsand other medical products.[1][2][3]Subgroup M04 is part of the anatomical groupMMusculo-skeletal system.[4]
Codes forveterinaryuse (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example,QM04.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
- M04AA01Allopurinol
- M04AA02Tisopurine
- M04AA03Febuxostat
- M04AA51 Allopurinol, combinations
M04AB Preparationsincreasing uric acid excretion
[edit]- M04AB01Probenecid
- M04AB02Sulfinpyrazone
- M04AB03Benzbromarone
- M04AB04Isobromindione
- M04AB05Lesinurad
M04AC Preparations with no effect on uric acid metabolism
[edit]- M04AC01Colchicine
- M04AC02Cinchophen
- M04AC51 Colchicine andprobenecid
M04AX Other antigout preparations
[edit]- M04AX01Urate oxidase
- M04AX02Pegloticase
References
[edit]- ^"ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis".National Institutes of Health.Retrieved1 February2020.
- ^World Health Organization."Anatomical Therapeutic Chemical (ATC) Classification".World Health Organization.Retrieved3 January2022.
- ^"Structure and principles".WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018.Retrieved3 January2022.
- ^"ATC/DDD Index 2022: code M04".WHO Collaborating Centre for Drug Statistics Methodology.
- ^"ATCvet Index 2022: code QM04".WHO Collaborating Centre for Drug Statistics Methodology.